Development of anti-factor H auto-antibodies genetically predisposed in atypical HUS

被引:2
|
作者
Dragon-Dureya, Marie-Agnes
Loirat, Chantal
Ranchin, Bruno
Davidovits, Miriam
Takagi, Nobuaki
Blouin, Jacques
Fridman, Wolf Herman
Fremeaux-Bacchi, Veronique
机构
[1] Hop Europeen Georges Pomidou, Serv Immunol Biol, Assistance Publ Hop Paris, Paris, France
[2] Univ Paris 05, UMRS 872, Ctr Rech Cordeliers, Paris, France
[3] Hop Robert Debre, Assistance Publ Hop Paris, Serv Nephrol, F-75019 Paris, France
[4] Hospices Civils Lyon, Hop Edouard Herriot, Dept Pediat, Lyon, France
[5] Schneider Childrens Med Ctr Israel, Pediat Nephrol & Dialysis Unit, Tel Aviv, Israel
关键词
D O I
10.1016/j.molimm.2007.06.036
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:3922 / 3922
页数:1
相关论文
共 50 条
  • [1] Successful Treatment of Atypical HUS Due to Factor H Auto-Antibodies by Eculizumab
    Jacoby, U.
    Staude, H.
    Von Osten, H.
    Zipfel, P. F.
    Wigger, M.
    PEDIATRIC NEPHROLOGY, 2014, 29 (09) : 1848 - 1848
  • [2] Anti-factor H auto-antibodies in C3 glomerulopathy
    Dragon-Durey, M. A.
    Blanc, C.
    Roumenina, L.
    Chauvet, S.
    Ashraf, Y.
    Moulin, B.
    Le Pogamp, P.
    Fremeaux-Bacchi, V.
    Fridman, W. H.
    MOLECULAR IMMUNOLOGY, 2011, 48 (14) : 1724 - 1724
  • [3] Specific treatment for HUS due to anti-Factor H antibodies
    Dragon-Durey, MA
    Loirat, C
    Davidovits, M
    Macher, MA
    Cloarec, C
    Blouin, J
    Nivet, H
    Cleper, R
    Fridman, WH
    Frémeaux-Bacchi, V
    MOLECULAR IMMUNOLOGY, 2006, 43 (1-2) : 129 - 129
  • [4] Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses
    Gwenaëlle Sana
    Marie-Agnès Dragon-Durey
    Marina Charbit
    Karim Bouchireb
    Caroline Rousset-Rouvière
    Etienne Bérard
    Rémi Salomon
    Véronique Frémeaux-Bacchi
    Patrick Niaudet
    Olivia Boyer
    Pediatric Nephrology, 2014, 29 : 75 - 83
  • [5] Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses
    Sana, Gwenaelle
    Dragon-Durey, Marie-Agnes
    Charbit, Marina
    Bouchireb, Karim
    Rousset-Rouviere, Caroline
    Berard, Etienne
    Salomon, Remi
    Fremeaux-Bacchi, Veronique
    Niaudet, Patrick
    Boyer, Olivia
    PEDIATRIC NEPHROLOGY, 2014, 29 (01) : 75 - 83
  • [6] Anti-Factor H auto-antibodies in atypical Hemolytic Uremic syndrome and membrano-proliferative glomerulonephritis: Non-univocal histories
    Dragon-Durey, M. -A.
    Blanc, C.
    Loirat, C.
    Roumenina, L.
    Moulin, B.
    Le Pogamp, P.
    Fremeaux-Bacchi, V.
    Fridman, W. H.
    MOLECULAR IMMUNOLOGY, 2009, 46 (14) : 2840 - 2840
  • [7] Anti-factor H antibodies-induced HUS: New pathogenesis and successful treatment
    Davidovits, M.
    Dragon-Durey, M. A.
    Krause, I.
    Adam, D.
    Cleper, R.
    PEDIATRIC NEPHROLOGY, 2007, 22 (09) : 1619 - 1619
  • [8] Anti-factor H antibodies in Japanese children with atypical hemolytic uremic syndrome
    Nishimura, M.
    Maekawa, K.
    Kawashima, F.
    Takagi, N.
    Sawaki, J.
    Takahashi, C.
    Mae, H.
    Hattori, M.
    Tanizawa, T.
    PEDIATRIC NEPHROLOGY, 2011, 26 (09) : 1640 - 1640
  • [9] Eculizumab in Anti-Factor H Antibodies Associated With Atypical Hemolytic Uremic Syndrome
    Chiodini, Benedetta Diamante
    Davin, Jean-Claude
    Corazza, Francis
    Khaldi, Karim
    Dahan, Karin
    Ismaili, Khalid
    Adams, Brigitte
    PEDIATRICS, 2014, 133 (06) : E1764 - E1768
  • [10] Eculizumab In Anti-factor H Antibodies-associated Atypical Hemolytic Uremic Syndrome
    Chiodini, Benedetta
    Davin, Jean-claude
    Corazza, Francis
    Khaldi, Karim
    Dahan, Karin
    Ismaili, Khalid
    Adams, Brigitte
    PEDIATRIC NEPHROLOGY, 2014, 29 (09) : 1784 - 1785